Cargando…

Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy

Xanthine oxidoreductase (XOR) is a critical enzyme in purine metabolism and uric acid production, and its levels are reported to increase during stress, thereby promoting organ damage. Herein, we investigated the activity of XOR in a mouse model of aristolochic acid I (AA)‐induced nephropathy, a typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Takeo, Kumagae, Tomohiro, Wakui, Hiromichi, Urate, Shingo, Tanaka, Shohei, Abe, Eriko, Suzuki, Toru, Yamaji, Takahiro, Kinguchi, Sho, Kobayashi, Ryu, Haruhara, Kotaro, Nakamura, Takashi, Kobayashi, Shuzo, Tamura, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876505/
https://www.ncbi.nlm.nih.gov/pubmed/33448693
http://dx.doi.org/10.1002/2211-5463.13083
_version_ 1783649988437344256
author Ishii, Takeo
Kumagae, Tomohiro
Wakui, Hiromichi
Urate, Shingo
Tanaka, Shohei
Abe, Eriko
Suzuki, Toru
Yamaji, Takahiro
Kinguchi, Sho
Kobayashi, Ryu
Haruhara, Kotaro
Nakamura, Takashi
Kobayashi, Shuzo
Tamura, Kouichi
author_facet Ishii, Takeo
Kumagae, Tomohiro
Wakui, Hiromichi
Urate, Shingo
Tanaka, Shohei
Abe, Eriko
Suzuki, Toru
Yamaji, Takahiro
Kinguchi, Sho
Kobayashi, Ryu
Haruhara, Kotaro
Nakamura, Takashi
Kobayashi, Shuzo
Tamura, Kouichi
author_sort Ishii, Takeo
collection PubMed
description Xanthine oxidoreductase (XOR) is a critical enzyme in purine metabolism and uric acid production, and its levels are reported to increase during stress, thereby promoting organ damage. Herein, we investigated the activity of XOR in a mouse model of aristolochic acid I (AA)‐induced nephropathy, a type of nephrotoxic chronic kidney disease (CKD). A persistent decrease in renal function was observed in mice up to 4 weeks after 4 weeks of AA (2.5 mg kg(−1)) administration. Renal histology revealed an increase in tubular interstitial fibrosis over time. Although AA administration did not change XOR activity in the plasma, heart, liver, or muscle, XOR activity was persistently increased in renal tissue. Our results suggest that the renal tissue‐specific increase in XOR activity is involved in the progression of tubulo‐interstitial disorders, specifically fibrosis.
format Online
Article
Text
id pubmed-7876505
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78765052021-02-18 Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy Ishii, Takeo Kumagae, Tomohiro Wakui, Hiromichi Urate, Shingo Tanaka, Shohei Abe, Eriko Suzuki, Toru Yamaji, Takahiro Kinguchi, Sho Kobayashi, Ryu Haruhara, Kotaro Nakamura, Takashi Kobayashi, Shuzo Tamura, Kouichi FEBS Open Bio Research Articles Xanthine oxidoreductase (XOR) is a critical enzyme in purine metabolism and uric acid production, and its levels are reported to increase during stress, thereby promoting organ damage. Herein, we investigated the activity of XOR in a mouse model of aristolochic acid I (AA)‐induced nephropathy, a type of nephrotoxic chronic kidney disease (CKD). A persistent decrease in renal function was observed in mice up to 4 weeks after 4 weeks of AA (2.5 mg kg(−1)) administration. Renal histology revealed an increase in tubular interstitial fibrosis over time. Although AA administration did not change XOR activity in the plasma, heart, liver, or muscle, XOR activity was persistently increased in renal tissue. Our results suggest that the renal tissue‐specific increase in XOR activity is involved in the progression of tubulo‐interstitial disorders, specifically fibrosis. John Wiley and Sons Inc. 2021-02-01 /pmc/articles/PMC7876505/ /pubmed/33448693 http://dx.doi.org/10.1002/2211-5463.13083 Text en © 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Ishii, Takeo
Kumagae, Tomohiro
Wakui, Hiromichi
Urate, Shingo
Tanaka, Shohei
Abe, Eriko
Suzuki, Toru
Yamaji, Takahiro
Kinguchi, Sho
Kobayashi, Ryu
Haruhara, Kotaro
Nakamura, Takashi
Kobayashi, Shuzo
Tamura, Kouichi
Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
title Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
title_full Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
title_fullStr Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
title_full_unstemmed Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
title_short Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
title_sort tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876505/
https://www.ncbi.nlm.nih.gov/pubmed/33448693
http://dx.doi.org/10.1002/2211-5463.13083
work_keys_str_mv AT ishiitakeo tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT kumagaetomohiro tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT wakuihiromichi tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT urateshingo tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT tanakashohei tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT abeeriko tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT suzukitoru tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT yamajitakahiro tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT kinguchisho tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT kobayashiryu tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT haruharakotaro tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT nakamuratakashi tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT kobayashishuzo tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy
AT tamurakouichi tissuexanthineoxidoreductaseactivityinamousemodelofaristolochicacidnephropathy